Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

L.A. McKeown

July 12, 2023

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

L.A. McKeown

July 02, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

L.A. McKeown

January 29, 2020

News Daily News

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

Todd Neale

November 04, 2019

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

Yael L. Maxwell

January 09, 2019

News Daily News

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Caitlin E. Cox

June 11, 2018

Advertisement

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

New Carotid Stent Systems Associated With Low Stroke Risk

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

What’s Going to Be Hot at TCT 2023

CMS Issues Proposed Coverage Decision to Broaden Access for Carotid Stenting

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Lutonix BTK Studies: Below-the-Knee Challenges Linger

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content